(2S)-2-[[5-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]imidazole-4-carbonyl]amino]butanedioic acid
中文别名:
化合物 T16837;N-琥珀酰-5-氨基咪唑-4-甲酰胺核糖5'-磷酸
英文名称:
(2S)-2-[[5-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]imidazole-4-carbonyl]amino]butanedioic acid
英文别名:
(2S)-2-[[5-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]imidazole-4-carbonyl]amino]butanedioic acid;N-[[5-Amino-1-(5-O-phosphono-β-D-ribofuranosyl)-1H-imidazol-4-yl]carbonyl]-L-aspartic acid;Succino-AICAR;2-[[1-(5-O-Phosphono-β-D-ribofuranosyl)-5-amino-1H-imidazol]-4-ylcarbonylamino]succinic acid;5-Aminoimidazole-4-N-succinocarboxamide ribonucleotide;5'-Phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole;N-Succinyl-5-aMinoiMidazole-4-carboxaMide Ribose 5'-Phosphate;SAICAR
密度:
2.18±0.1 g/cm3(Predicted)
产品用途:
N-琥珀酰基-5-氨基咪唑-4-羧酰胺5'-磷酸核糖是嘌呤代谢产物。 由于腺苷是神经元功能的有效抑制剂,可抑制几种兴奋递质的释放并引发神经元的直接过级化,因此腺苷琥珀酸裂合酶(ASase)缺乏症患者出现的症状可能反映了琥珀酰嘌呤对神经传递的干扰。